Insider filing · AGL

Girish Venkatachaliah bought $955K of agilon health (AGL)

Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Mar 18 2025), the stock returned +32.9% (delay-adjusted); from the execution session (Mar 14 2025), +39.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

GV Girish Venkatachaliah Chief Technology Officer profile →

Girish Venkatachaliah (Chief Technology Officer) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in AGL. Across 1 priced purchase filing, the average 21-session return was +12.5% from execution and +39.2% from disclosure (delay-adjusted; derived). The largest single filing was $277K of AGL (as filed, as filed), executed Mar 9.

AGL AGL AGL · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→